Skip to content
News
Data
Podcast
Clinics
News
Data
Podcast
Clinics
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
News
Data
Podcast
Clinics
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Cellbricks Therapeutics sec...
Maze Therapeutics reports p...
Human Longevity, Inc. to st...
Rubedo reports positive pha...
20/20 BioLabs secures exclu...
Cellbricks Therapeutics sec...
Maze Therapeutics reports p...
Human Longevity, Inc. to st...
Rubedo reports positive pha...
20/20 BioLabs secures exclu...
Latest Articles
Biotech
Rubedo reports early clinical signal for senotherapeutic drug
Biotech
Higher dose semaglutide gets fast FDA nod amid patent pressure
Biotech
Pulmatrix and Eos merge to advance gerotherapeutics
Ecosystem
The oldest old become longevity biotech’s new map
Biotech
Immutrin bags $87m for heart amyloid therapy
Ecosystem
Why the wellness industry needs a new operating system
Investment
SEMCAP expands into beauty’s longevity opportunity
Investment
Herbalife to acquire personalized supplements company Bioniq
Biotech
Dual gene therapy targets muscle aging
Lt Wire
Cellbricks Therapeutics secures €10 million to advance tissue implants
Maze Therapeutics reports positive phase 2 data for MZE829
Human Longevity, Inc. to study centenarians with LEV Foundation
Rubedo reports positive phase 1 results for RLS-1496
20/20 BioLabs secures exclusive US license for CKD prediction
EU updates review of blarcamesine from Anavex
Cognito and Ochsner launch brain health collaboratory
Your daily longevity briefing
The latest longevity science, investment, innovation and insights-delivered every morning.
Email Address
(Required)
This field is hidden when viewing the form
Contact Source
CAPTCHA
Investment
SEMCAP expands into beauty’s longevity opportunity
Pulmatrix and Eos merge to advance gerotherapeutics
Herbalife to acquire personalized supplements company Bioniq
Autophagy angle sharpens Anavex’s investment case for Alzheimer’s
Sequential banks $3.5m for smarter skin health
R1 launches with $77.5m for chronic kidney disease drug
Longevity public stocks are investable: here’s a DLT Chatbot guide
Ternary raises $4.4m to fight inflammaging with AI drugs
Biotech
Rubedo reports early clinical signal for senotherapeutic drug
Higher dose semaglutide gets fast FDA nod amid patent pressure
Immutrin bags $87m for heart amyloid therapy
Pulmatrix and Eos merge to advance gerotherapeutics
Dual gene therapy targets muscle aging
Research links GLP-1s to osteoporosis and gout risks
Autophagy angle sharpens Anavex’s investment case for Alzheimer’s
Parallel Health’s skin microbiome tool aims at precision aging care
Research
Rubedo reports early clinical signal for senotherapeutic drug
The oldest old become longevity biotech’s new map
Research links GLP-1s to osteoporosis and gout risks
NOVOS trial explores vascular aging markers
AI/tech diagnostics
Brain health ‘collaboratory’ focuses on non-invasive Alzheimer’s therapy
Perplexity enters the consumer health AI arena
Startup targets ‘untreatable blindness’ with bionic eye system
Science Corp lands $230m to commercialize vision restoration chip
Supplements
MUSCLE: FLT’s revolutionary AI-powered supplement for strength and longevity
Ergothioneine: The little-known molecule transforming brain health and longevity
COGNITION: FLT’s new brain-boosting supplement that’s redefining mental performance
7 Best l-glutamine supplements to buy in 2024
Ecosystem
The oldest old become longevity biotech’s new map
Why the wellness industry needs a new operating system
GARM expands gene therapy platform with Klotho
The hidden bottleneck in longevity biotech
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
This field is hidden when viewing the form
Contact Source